CEA Grants NEB License to Patent that Covers a Process for Synthesis of Double Stranded RNA
News Feb 28, 2006
The CEA, a French government-funded research organisation, has announced that its life science division has granted New England Biolabs Inc. a non-exclusive license under the patent family EP10618966.
This license concerns some RNAi products that NEB supplies to its customers in the research reagent field.
This patent family, owned solely by the CEA, covers a process for an enzymatic synthesis of double-stranded RNA based on the transcription of a double-stranded DNA template.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019